Journal
TRENDS IN CANCER
Volume 2, Issue 12, Pages 736-746Publisher
CELL PRESS
DOI: 10.1016/j.trecan.2016.11.001
Keywords
-
Categories
Funding
- Fondazione Umberto Veronesi
- Associazione Italiana Ricerca sul Cancro (AIRC) [8797]
- Istituto Toscano Tumori [0203607]
- Programma operativo regionale Obiettivo 'Competitivita regionale e occupazione' della Regione Toscana cofinanziato dal Fondo europeo di sviluppo regionale (POR CReO FESR)
Ask authors/readers for more resources
The tumor microenvironment has an essential role in defining tumor malignancy, since it can either promote or prevent tumor initiation and subsequent progression and metastatic dissemination. Recent studies demonstrate that highly aggressive cancer cells display a high degree of metabolic plasticity paralleled by the acquisition of stemness and chemoresistant properties. In addition, cancer-associated fibroblasts, endothelial cells, and immune cells have an important role in shaping the metabolic behavior of cancer cells. This review discusses the current knowledge of metabolic reprogramming in cancer, the tumor-stroma metabolic crosstalk, and the available compounds that may be used to effectively target the tumor-stroma metabolic symbiosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available